{"pmid":32298473,"title":"Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.","text":["Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.","Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients but few are wholly equipped to manage this new disease. We all must do our part to prepare our patients, clinics, and hospitals for the drastic changes necessary to mitigate the spread of SARS-CoV-2 or we risk overwhelming the capacity of our healthcare system. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers.","Hepatology","Fix, Oren K","Hameed, Bilal","Fontana, Robert J","Kwok, Ryan M","McGuire, Brendan M","Mulligan, David C","Pratt, Daniel S","Russo, Mark W","Schilsky, Michael L","Verna, Elizabeth C","Loomba, Rohit","Cohen, David E","Bezerra, Jorge A","Reddy, K Rajender","Chung, Raymond T","32298473"],"abstract":["Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients but few are wholly equipped to manage this new disease. We all must do our part to prepare our patients, clinics, and hospitals for the drastic changes necessary to mitigate the spread of SARS-CoV-2 or we risk overwhelming the capacity of our healthcare system. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers."],"journal":"Hepatology","authors":["Fix, Oren K","Hameed, Bilal","Fontana, Robert J","Kwok, Ryan M","McGuire, Brendan M","Mulligan, David C","Pratt, Daniel S","Russo, Mark W","Schilsky, Michael L","Verna, Elizabeth C","Loomba, Rohit","Cohen, David E","Bezerra, Jorge A","Reddy, K Rajender","Chung, Raymond T"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298473","week":"202016|Apr 13 - Apr 19","doi":"10.1002/hep.31281","keywords":["SARS-CoV-2","cirrhosis","coronavirus","immunosuppression","transplantation"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"_version_":1664266651131969536,"score":8.233237,"similar":[{"pmid":32289115,"pmcid":"PMC7128473","title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.","text":["Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.","The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.","JHEP Rep","Boettler, Tobias","Newsome, Philip N","Mondelli, Mario U","Maticic, Mojca","Cordero, Elisa","Cornberg, Markus","Berg, Thomas","32289115"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention."],"journal":"JHEP Rep","authors":["Boettler, Tobias","Newsome, Philip N","Mondelli, Mario U","Maticic, Mojca","Cordero, Elisa","Cornberg, Markus","Berg, Thomas"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289115","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jhepr.2020.100113","keywords":["ACE-I, angiotensin-converting enzyme inhibitor","ACE2, angiotensin-converting enzyme 2","ACLF, acute-on-chronic liver failure","ALT, alanine aminotransferase","AST, aspartate aminotransferase","COVID-19, coronavirus disease 2019","EGD, esophagogastroduodenoscopy","ERC, endoscopic retrograde cholangiography","HCC, hepatocellular carcinoma","MELD, model for end-stage liver disease","NAFLD, non-alcoholic fatty liver disease","NASH, non-alcoholic steatohepatitis","NUC, nucleoside analogue","PIs, protease inhibitors","RdRp, RNA-dependent RNA polymerase","SARS-CoV-2, severe acute respiratory syndrome coronavirus 2","ULN, upper limit of normal"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664071627216781312,"score":248.44513},{"pmid":32277591,"title":"Fatal outcome in a liver transplant recipient with COVID-19.","text":["Fatal outcome in a liver transplant recipient with COVID-19.","Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation. We describe a case of COVID-19 in a patient who had transplantation three years previously for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multi-organ failure. Despite multiple invasive procedures and rescue therapies, he succumbed to the disease. The management of COVID-19 in the post-transplant setting presents complex challenges emphasizing the importance of strict prevention strategies.","Am J Transplant","Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua","32277591"],"abstract":["Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation. We describe a case of COVID-19 in a patient who had transplantation three years previously for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multi-organ failure. Despite multiple invasive procedures and rescue therapies, he succumbed to the disease. The management of COVID-19 in the post-transplant setting presents complex challenges emphasizing the importance of strict prevention strategies."],"journal":"Am J Transplant","authors":["Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277591","week":"202015|Apr 06 - Apr 12","doi":"10.1111/ajt.15909","keywords":["COVID-19","liver","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663798882972205057,"score":239.48248},{"pmid":32243673,"title":"Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.","text":["Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.","Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.","Am J Transplant","Bin, Liu","Yangzhong, Wang","Yuanyuan, Zhao","Huibo, Shi","Fanjun, Zeng","Zhishui, Chen","32243673"],"abstract":["Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Bin, Liu","Yangzhong, Wang","Yuanyuan, Zhao","Huibo, Shi","Fanjun, Zeng","Zhishui, Chen"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243673","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15901","keywords":["coronavirus disease 2019","liver","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352135731904516,"score":234.20949},{"pmid":32233055,"title":"Lest we forget.","text":["Lest we forget.","The severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic has caused shockwaves throughout the US healthcare system. Nowhere has coronavirus 19 (COVID-19) caused more infections than in New York, where there have been over 26,500 infections. Resources have been appropriately allocated towards combating this outbreak, but where does this leave patients with severe non-COVID-19 diseases? Herein we provide the views of a liver transplant surgeon and transplant hepatologist in New York.","Am J Transplant","Halazun, Karim J","Rosenblatt, Russell","32233055"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic has caused shockwaves throughout the US healthcare system. Nowhere has coronavirus 19 (COVID-19) caused more infections than in New York, where there have been over 26,500 infections. Resources have been appropriately allocated towards combating this outbreak, but where does this leave patients with severe non-COVID-19 diseases? Herein we provide the views of a liver transplant surgeon and transplant hepatologist in New York."],"journal":"Am J Transplant","authors":["Halazun, Karim J","Rosenblatt, Russell"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233055","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15888","source":"PubMed","locations":["New York","US"],"countries":["United States"],"countries_codes":["USA|United States"],"weight":0,"_version_":1663352135330299904,"score":221.30515},{"pmid":32259288,"title":"Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel.","text":["Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel.","Chronic pain causes significant suffering, limitation of daily activities and reduced quality of life. Infection from COVID-19 is responsible for an ongoing pandemic that causes severe acute respiratory syndrome, leading to systemic complications and death. Led by the World Health Organization, healthcare systems across the world are engaged in limiting the spread of infection. As a result all elective surgeries, procedures, and patient visits, including pain management services, have been postponed or cancelled. This has impacted the care of chronic pain patients. Most are elderly with multiple comorbidities, which puts them at risk of COVID-19 infection. Important considerations that need to be recognised during this pandemic for chronic pain patients include: ensuring continuity of care and pain medications, especially opioids; use of telemedicine; maintaining biopsychosocial management; use of anti-inflammatory drugs; use of steroids; and prioritising necessary procedural visits. There are no guidelines to inform physicians and healthcare providers engaged in caring for patients with pain during this period of crisis. We assembled an expert panel of pain physicians, psychologists and researchers from North America and Europe to formulate recommendations to guide practice. As the COVID-19 situation continues to evolve rapidly, these recommendations are based on the best available evidence and expert opinion at this present time and may need adapting to local workplace policies.","Anaesthesia","Shanthanna, H","Strand, N H","Provenzano, D A","Lobo, C A","Eldabe, S","Bhatia, A","Wegener, J","Curtis, K","Cohen, S P","Narouze, S","32259288"],"abstract":["Chronic pain causes significant suffering, limitation of daily activities and reduced quality of life. Infection from COVID-19 is responsible for an ongoing pandemic that causes severe acute respiratory syndrome, leading to systemic complications and death. Led by the World Health Organization, healthcare systems across the world are engaged in limiting the spread of infection. As a result all elective surgeries, procedures, and patient visits, including pain management services, have been postponed or cancelled. This has impacted the care of chronic pain patients. Most are elderly with multiple comorbidities, which puts them at risk of COVID-19 infection. Important considerations that need to be recognised during this pandemic for chronic pain patients include: ensuring continuity of care and pain medications, especially opioids; use of telemedicine; maintaining biopsychosocial management; use of anti-inflammatory drugs; use of steroids; and prioritising necessary procedural visits. There are no guidelines to inform physicians and healthcare providers engaged in caring for patients with pain during this period of crisis. We assembled an expert panel of pain physicians, psychologists and researchers from North America and Europe to formulate recommendations to guide practice. As the COVID-19 situation continues to evolve rapidly, these recommendations are based on the best available evidence and expert opinion at this present time and may need adapting to local workplace policies."],"journal":"Anaesthesia","authors":["Shanthanna, H","Strand, N H","Provenzano, D A","Lobo, C A","Eldabe, S","Bhatia, A","Wegener, J","Curtis, K","Cohen, S P","Narouze, S"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259288","week":"202015|Apr 06 - Apr 12","doi":"10.1111/anae.15076","keywords":["COVID-19","chronic pain","opioids","recommendations","steroids"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663450393565200384,"score":219.35219}]}